Comparative study of platelet activation markers in diabetes mellitus patients complicated by cerebrovascular disease

Blood Coagulation and Fibrinolysis

Volumn 12, Issue 7, 2001, Pages 531-537

  Wang, Z Y ^a   Shi, J M ^a   Han, Y ^a   Wang, Y C ^a   Ruan, C G ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Cerebrovascular disease; Dehydro thromboxane; Diabetes mellitus; Glycoprotein; Platelet

Indexed keywords

11 OXOTHROMBOXANE B2; FIBRINOGEN; GLYCOPROTEIN; PADGEM PROTEIN; THROMBOXANE B2;

ADULT; AGED; ARACHIDONIC ACID METABOLISM; ARTICLE; BLOOD LEVEL; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE; VASCULAR DISEASE;

ADULT; AGED; ARACHIDONIC ACID; BIOLOGICAL MARKERS; BLOOD PLATELETS; CEREBROVASCULAR DISORDERS; DIABETES MELLITUS, TYPE 2; HUMANS; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBOXANE B2;

EID: 0034751605     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200110000-00004     Document Type: Article

References (30)

1. Hyperglycemia, diabetes and vascular disease: A overview
2. Long-term complications of diabetes mellitus
3. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
4. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall Study
5. Platelet abnormalities in diabetes mellitus
6. Changes in blood coagulation, platelet function, and plasminogen-plasmin system in diabetes
7. In vivo platelet activation in diabetes mellitus
8. Laboratory techniques of molecular markers
9. 2 formation in the human circulation
10. WHO Special Report Stroke - 1989: Recommendations on stroke prevention, diagnosis, and therapy
11. 1α
12. 2 and prostacyclin
13. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry
14. A murine antiglycoprotein Ib complex monoclonal antibody, SZ2, inhibits platelet aggregation induced by both ristocetin and collagen
15. Studies on a monoclonal antibody to platelet membrane glycoprotein IIb - SZ-22
16. Studies on monoclonal antibodies on monoclonal antibody SZ-21 to platelet membrane glycoprotein III
17. Preparation of a monoclonal antibody, SZ-51, that recognizes an α-granule membrane protein (GMP-140) on the surface of activated human platelets
18. 125I-labeled monoclonal antibodies
19. Plasma P-selectin measurement using immunoassay method and its clinical significance
20. Platelet activation markers in patients with peripheral arterial disease
21. The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes
22. Evaluation of platelet membrane glycoproteins in coronary artery disease: Consequences for diagnosis and therapy
23. P-Selectin and platelet clearance
24. Production of soluble P-selectin by platelets and endothelial cells
25. Pro-coagulant state resulting from high levels of soluble P-selectin in blood
26. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients
27. Soluble P-selectin in hyperlipidaemia with and without symptomatic vascular disease: Relationship with von Willebrand factor
28. Bidirectional trafficking of membrane glycoproteins following platelet activation in suspension
29. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex
30. Direct detection of activated platelets and platelet-derived microparticles in humans